Abstract
Heart failure (HF) is a leading cause of hospitalization and mortality worldwide. Yet, there is still limited knowledge on the underlying molecular mechanisms, because human tissue for research is scarce, and data obtained in animal models is not directly applicable to humans. Thus, studies of human heart specimen are of particular relevance. Mitochondrial Ca2+ handling is an emerging topic in HF progression because its regulation is central to the energy supply of the heart contractions as well as to avoiding mitochondrial Ca2+ overload and the ensuing cell death induction. Notably, animal studies have already linked impaired mitochondrial Ca2+ transport to the initiation/progression of HF. Mitochondrial Ca2+ uptake is mediated by the Ca2+uniporter (mtCU) that consists of the MCU pore under tight control by the Ca2+-sensing MICU1 and MICU2. The MICU1/MCU protein ratio has been validated as a predictor of the mitochondrial Ca2+ uptake phenotype.
We here determined for the first time the protein composition of the mtCU in the human heart. The two regulators MICU1 and MICU2, were elevated in the failing human heart versus non-failing controls, while the MCU density was unchanged. Furthermore, the MICU1/MCU ratio was significantly elevated in the failing human hearts, suggesting altered gating of the MCU by MICU1 and MICU2. Based on a small cohort of patients, the decrease in the cardiac contractile function (ejection fraction) seems to correlate with the increase in MICU1/MCU ratio. Our findings therefore indicate a possible role for adaptive/maladaptive changes in the mtCU composition in the initiation/progression of human HF in humans and point to a potential therapeutic target at the level of the MICU1-dependent regulation of the mtCU.
Keywords: Heart failure, Mitochondrial Ca2+ signaling, Mitochondrial calcium uniporter, MICU1, MICU2, Human cardiac biopsy, cardiomyopathy, HFrEF
1. Introduction
Impaired mitochondrial Ca2+ exchange is linked to heart failure (HF) development and progression. Sarcoplasmic Ca2+ oscillations are crucial to cardiomyocyte contraction, and their propagation to the mitochondrial matrix regulates Krebs cycle flux to match ATP production to the contractile workload of the heart. However, excessive mitochondrial Ca2+ uptake can also cause mitochondrial dysfunction, permeability transition and cell death. Thus, mitochondrial Ca2+uptake across the inner mitochondrial membrane needs to be tightly controlled. Mitochondrial Ca2+uptake is mediated by the mitochondrial Ca2+ uniporter channel (mtCU), which consists of tetramers of the pore-forming subunit, MCU, its essential scaffold, EMRE and the Ca2+-sensing regulator, MICU1 that dimerizes with MICU2, MICU3 or itself.
MCU-knockout mice did not have an overt cardiac phenotype [1], but inducible cardiac deletion of MCU led to impaired fight-to-flight response and protected against ischemia-reperfusion injury [2,3]. Functional studies revealed that the regulation of the mtCU by MICUs is tissue-specific, and in mouse heart, MICU1 is expressed in limiting quantity [4]. In mice, MICU1 knockdown by siRNA was shown to exacerbate cardiac ischemia-reperfusion injury [5], suggesting a protective role for MICU1-dependent gating of the mtCU against mitochondrial Ca2+ overload. On the other hand, cardiac MICU1 overexpression triggered contractile dysfunction, suggesting a shift in the MICU1/MCU ratio might interfere with decoding of cardiomyocyte intracellular Ca2+ oscillations by the mitochondria [4]. In a guinea pig model of severe pressure-overload, a small increase in MCU expression was reported to have a beneficial effect by restoring the mitochondrial Ca2+ content and improving left ventricular function [6]. The MCU paralog, MCUb, has also been reported to be altered in animal models of myocardial infarction [7] or catecholaminergic polymorphic ventricular tachycardia [8]; suggesting yet another mechanism of direct regulation of mtCU structure and function.
The human heart operates at a much lower frequency range than the rodent heart and thus, MICU1 might have a more significant physiological role in decoding Ca2+ spikes and contribute differently to HF pathogenesis in humans. Other reports showed that mRNA is elevated for both MICU1 and MICU2 in failing human hearts [9,10]. Whether these mRNA changes are translated into differences in protein expression remains to be determined. Here, our objective was to determine the protein composition of the mtCU in the human failing heart.
2. Materials and methods
Patient consent, clinical data collection, sample collection and preparation were all performed according to a protocol approved by the Lewis Katz School of Medicine Institutional Review Board. Definition of HF etiology was based on the patient diagnosis as reported in the ICD codes. In general terms, non-ischemic HF suggests some suspected causes such as dilated cardiomyopathy, hypertension or something else, yet no ischemic event, while idiopathic suggests unknown cause. Resting transthoracic echocardiography was performed to calculate the left ventricular ejection fraction (LVEF) and data were acquired post-hoc from patient charts. Left ventricle biopsies were obtained after cardiectomy at the time of transplant from 7 non-failing patients (from unused donor hearts) and 15 HF patients (3 non-ischemic, 7 ischemic and 5 with idiopathic HF). The mean age of the HF patients was 54 [48;61] versus 60 [58;72] years in non-failing patients (p < 0.05, Mann-Whitney test, median [IQ25; IQ75]). 86% of non-failing patients were female versus 20% in the HF cohort.
Immunoblotting was performed on RIPA-lysed frozen cardiac tissue, using the following antibodies: MICU1 (Sigma, HPA037480), MCU (Sigma, HPA016480), MICU2 (Abcam, ab101465), EMRE (SantaCruz, sc-86,337), MCUB (sc-163,985), mitochondrial Hsp70 (ThermoFisher, MA3–028) and OxPhos cocktail (ab110413). Specificity of the antibodies was confirmed using lysates of HEK293 human cell lines deleted for each mtCU component (Supplementary Figure 1) [11-13].
Statistical analysis was performed on GraphPad and on Python, Scikit-learn.
3. Results and discussion
The protein level of MCU and EMRE were indistinguishable between non-failing and failing hearts (Fig 1A-C). No change was observed for MCUB, when corrected to complex I as a mitochondrial loading control (Supplementary Figure 2). By contrast, MICU1 and MICU2 protein levels were increased ~two-fold in cardiac samples isolated from failing hearts (Fig. 1D,E). Calculation of the expression ratio between the different mtCU components for each patient revealed a two-fold increase in the MICU1/MCU ratio in failing hearts, as compared to non-failing controls (Fig. 1F), while the MICU2/MCU and EMRE/MCU ratios were not significantly altered (data not shown). Multivariate analysis by principal component analysis (PCA) revealed a significant divergence between the non-failing and HF patients (p < 0.001, Mann-Whitney Rank Sum Test), as displayed by their scattering along the first PC (70% of variance) calculated as 0.85*MICU1 + 0.50*MICU2 + 0.16*MCU - 0.017*EMRE. This indicates that the rightward samples, mainly the failing heart biopsies, are associated with high MICU1, MICU2 and to a lesser extent, MCU (Fig. 1G). Pairwise comparison further deciphered a significant difference between idiopathic and ischemic biopsies (p = 0.026). Interestingly, the range/variance of protein expression for MICU1 and MICU2 was also greater in the HF group, which may reflect differences in the clinical status of each donor patient. Reliable clinical data were scarce for the present cohort, but the LVEF was available for 5 non-failing and 10 HF patients: the MICU1/MCU ratio increase correlated with LVEF decrease in the dataset (Fig. 1H, Spearman Rank Order Correlation: −0.699, p = 0.00326).
Fig. 1.
Evaluation of mtCU subunit protein composition in failing human hearts. A) Representative immunoblots for various mtCU components. B–E) Quantification of the relative protein level of MCU (B), EMRE (C), MICU2 (D) and MICU1 (E) in heart lysates isolated from 7 non-failing and 15 HF patients, normalized to the mitochondrial housekeeping protein, Hsp70.
F) Protein ratios of MICU1 to MCU, calculated individually for each patient. Statistical analysis was performed on GraphPad (Mann-Whitney test).
G) Principal component analysis (on Python, Scikit-learn) shows the first and second principle components of the multi-variate scattering of all patients by the variance of the mtCU protein level.
H) Dot plot between LVEF and MICU1/MCU ratio in non-failing and failing patients.
These results provide evidence that the overall abundance of the mtCU (uniporter channel density) is unchanged, whereas the channel composition or regulatory subunit stoichiometry is altered in the failing human heart, signified by an increase in the MICU1 to MCU ratio. We propose that this molecular change leads to increased gating of the mtCU by MICU, which might serve as a compensatory mechanism to prevent mitochondrial Ca2+ overload in the stressed/diseased heart. However, a chronic increase in the MICU1/MCU ratio may turn maladaptive leading to an altered decoding of intracellular Ca2+ oscillations by mitochondria, therefore contributing to impairments in energy metabolism and contractile dysfunction. Although admittedly our study included a small number of patients, the results revealed a correlation between the MICU1/MCU ratio and decrease in cardiac contractility. This observation will stimulate in-depth studies of the clinical phenotype to test the correlation between changes in the mtCU composition and clinical endpoints. In summary, these results suggest that MICU1-dependent regulation of the mtCU may be a potential therapeutic target in HF. To test this, further studies are required on fresh cardiac biopsies from HF patients to perform functional analysis of the mtCU in correlation with clinical outcomes to decipher the contribution of the mtCU in HF with reduced or preserved ejection fraction.
Supplementary Material
Funding
This study was funded by RO1HL142271 to GH and JE, RF1NS121379 to JE, and by a Leducq Foundation grant (MitoCardia 16CVD04). MP was a recipient of a postdoctoral fellowship from the Fondation pour la Recherche Médicale (n°ARF20160936149) and a grant from the Agence Nationale de la Recherche (ANR- 20-CE14–0013–01).
Footnotes
CRediT author statement
Melanie Paillard: Conceptualization, Investigation, Formal Analysis, Original draft preparation. Kai-Ting Huang: Investigation, Methodology. David Weaver: Formal Analysis, Validation. Jonathan P. Lambert: Investigation, Methodology. John W. Elrod: Writing- Reviewing and Editing, Funding Acquisition. György Hajnóczky: Conceptualization, Writing- Reviewing and Editing, Funding Acquisition, Supervision
Supplementary materials
Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.ceca.2022.102618.
Declaration of Competing Interest
None
Data Availability
No data was used for the research described in the article.
References
- [1].Pan X, Liu J, Nguyen T, Liu C, Sun J, Teng Y, Fergusson MM, Rovira II, Allen M, Springer DA, Aponte AM, Gucek M, Balaban RS, Murphy E, Finkel T, The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter, Nat. Cell Biol 15 (2013) 1464–1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [2].Kwong JQ, Lu X, Correll RN, Schwanekamp JA, Vagnozzi RJ, Sargent MA, York AJ, Zhang J Bers DM, Molkentin JD, The mitochondrial calcium uniporter selectively matches metabolic output to acute contractile stress in the heart, Cell Rep. 12 (2015) 15–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Luongo TS, Lambert JP, Yuan A, Zhang X, Gross P, Song J, Shanmughapriya S, Gao E, Jain M, Houser SR, Koch WJ, Cheung JY, Madesh M, Elrod JW, The mitochondrial calcium uniporter matches energetic supply with cardiac workload during stress and modulates permeability transition, Cell Rep. 12 (2015) 23–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Paillard M, Csordas G, Szanda G, Golenar T, Debattisti V, Bartok A, Wang N, Moffat C, Seifert EL, Spat A, Hajnoczky G, Tissue-specific mitochondrial decoding of cytoplasmic Ca2+ signals is controlled by the stoichiometry of MICU1/2 and MCU, Cell Rep. 18 (2017) 2291–2300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Xue Q, Pei H, Liu Q, Zhao M, Sun J, Gao E, Ma X, Tao L, MICU1 protects against myocardial ischemia/reperfusion injury and its control by the importer receptor Tom70, Cell Death Dis. 8 (2017) e2923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Liu T, Yang N, Sidor A, O’Rourke B, MCU overexpression rescues inotropy and reverses heart failure by reducing SR Ca(2+) leak, Circ. Res 128 (2021) 1191–1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [7].Huo J, Lu S, Kwong JQ, Bround MJ, Grimes KM, Sargent MA, Brown ME, Davis ME, Bers DM, Molkentin JD, MCUb induction protects the heart from postischemic remodeling, Circ. Res 127 (2020) 379–390. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].Hamilton S, Terentyeva R, Martin B, Perger F, Li J, Stepanov A, Bonilla IM, Knollmann BC, Radwanski PB, Gyorke S, Belevych AE, Terentyev D, Increased RyR2 activity is exacerbated by calcium leak-induced mitochondrial ROS, Basic Res. Cardiol 115 (2020) 38. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Bick AG, Wakimoto H, Kamer KJ, Sancak Y, Goldberger O, Axelsson A, DeLaughter DM, Gorham JM, Mootha VK, Seidman JG, Seidman CE, Cardiovascular homeostasis dependence on MICU2, a regulatory subunit of the mitochondrial calcium uniporter, Proc. Natl. Acad. Sci. U. S. A 114 (2017) E9096–E9104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Luongo TS, Lambert JP, Gross P, Nwokedi M, Lombardi AA, Shanmughapriya S, Carpenter AC, Kolmetzky D, Gao E, van Berio JH, Tsai EJ, Molkentin JD, Chen X, Madesh M, Houser SR, Elrod JW, The mitochondrial Na(+)/Ca(2+) exchanger is essential for Ca(2+) homeostasis and viability, Nature 545 (2017) 93–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [11].Paillard M, Csordas G, Huang KT, Varnai P, Joseph SK, Hajnoczky G, MICU1 interacts with the D-ring of the MCU pore to control its Ca(2+) flux and sensitivity to Ru360, Mol Cell 72 (2018) 778–785, e773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Patron M, Checchetto V, Raffaello A, Teardo E, Vecellio Reane D, Mantoan M, Granatiero V, Szabo I, De Stefani D, Rizzuto R, MICU1 and MICU2 finely tune the mitochondrial Ca2+ uniporter by exerting opposite effects on MCU activity, Mol. Cell 53 (2014) 726–737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Sancak Y, Markhard AL, Kitami T, Kovacs-Bogdan E, Kamer KJ, Udeshi ND, Carr SA, Chaudhuri D, Clapham DE, Li AA, Calvo SE, Goldberger O, Mootha VK, EMRE is an essential component of the mitochondrial calcium uniporter complex, Science 342 (2013) 1379–1382. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
No data was used for the research described in the article.